Erika N.

Dynamic Finance Professional

Role: Director of Finance at Abeona Therapeutics
Location: Morristown, NJ, US
LinkedIn followers: 500 followers

Finance & AccountingView LinkedIn profile

About Erika N.

Dynamic finance professional with experience in the pharmaceutical and hospitality industries; specializing in cash forecast modeling, general accounting and software solution/systems implementation and administration.

Experience

Director of Finance
Abeona Therapeutics
May 2022 — Present

Education

Fairleigh Dickinson University-Florham Campus
Bachelor’s Degree, Finance, General
2005 — 2007
Fairleigh Dickinson University-Florham Campus
Master of Business Administration (MBA), International Business
2007

Skills

Budgeting
Microsoft Office
Ultipro
Customer Service
Account Management
Strategic Planning
Planning Budgeting & Forecasting
Social Media
Microsoft Word
Frx Report Writer
Event Management
Quickbooks
Microsoft Excel
Powerpoint
Outlook
Budgets
Social Networking
Microsoft Dynamics
Concur
Management
Team Building

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@abeonatherapeutics.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Abeona Therapeutics

Biotechnology Research · 238 employees · Founded 2015 · Cleveland, Ohio, United States

Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona’s ZEVASKYN™ (prademagene zamikeracel) is the first and only autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). Abeona’s fully integrated cell and gene therapy cGMP manufacturing facility in Cleveland, Ohio serves as the manufacturing site for ZEVASKYN commercial production. The Company’s development portfolio features adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need. Abeona’s novel, next-generation AAV capsids are being evaluated to improve tropism profiles for a variety of devastating diseases.

abeonatherapeutics.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.